Welcome to Fierce Pharma’s 2024 regulatory tracker. We’re keeping track of the approval progress for pharmaceutical products, including their expansion […]

At a conference in New England, Rohan Simon, the associate director of a UAE-based contract research organization, spoke about the

LAMA2-CMD is a serious muscle disease caused by a missing protein called LAMA2, leading to early muscle weakness. The FDA

Ultra-processed foods (UPFs) in India are being linked to health issues like obesity, diabetes, heart disease, and some cancers. In

AbbVie, a pharmaceutical company, is buying Aliada Therapeutics for $1.4 billion. This purchase includes Aliada’s main experimental drug, ALIA-1758, which

A recent trial showed that nearly 60% of patients using Fasenra reached remission. The European Commission has approved Fasenra, a

At a conference on clinical trials in New England, the U.S. Customs and Border Protection (CBP) warned researchers about common

The MVA-BN vaccine, known as Jynneos in the US and Imvanex in Europe, is being tested to see if it

The US regulator is currently assessing an additional application for VTAMA cream to treat atopic dermatitis. Organon recently acquired Dermavant